Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

643 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Update on Hormonal Therapy in Hidradenitis Suppurativa.
Karagaiah P, Daveluy S, Ortega-Loayza A, Gulliver W, Szepietowski J, Grabbe S, Goldust M. Karagaiah P, et al. Among authors: szepietowski j. J Drugs Dermatol. 2023 Apr 1;22(4):369-374. doi: 10.36849/JDD.6235. J Drugs Dermatol. 2023. PMID: 37026880 Review.
External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort.
van Straalen KR, Tzellos T, Alavi A, Benhadou F, Cuenca-Barrales C, Daxhelet M, Daoud M, Efthymiou O, Giamarellos-Bourboulis EJ, Guillem P, Gulliver W, Jemec GBE, Katoulis A, Koenig A, Lazaridou E, Lowes MA, Marzano AV, Matusiak L, Molina-Leyva A, Moltrasio C, Pinter A, Potenza C, Prens EP, Romaní J, Saunte DM, Sayed C, Skroza N, Stergianou D, Szepietowski JC, Trigoni A, Vilarrasa E, Kyrgidis A, Zouboulis CC, van der Zee HH. van Straalen KR, et al. Among authors: szepietowski jc. Dermatology. 2023;239(3):362-367. doi: 10.1159/000528968. Epub 2023 Jan 30. Dermatology. 2023. PMID: 36630943 Free article.
Self-management-competency as a new target in Hidradenitis suppurativa care.
Mann C, Staubach P, Grabbe S, Wegner J, Hennig K, Nikolakis G, Szepietowski JC, Matusiak L, von Stebut E, Kirschner U, Podda M, Garcovich S, Schultheis M. Mann C, et al. Among authors: szepietowski jc. J Dermatolog Treat. 2023 Dec;34(1):2245082. doi: 10.1080/09546634.2023.2245082. J Dermatolog Treat. 2023. PMID: 37577779 Free article.
Hidradenitis Suppurativa Is Associated with Severe Sexual Impairment.
Krajewski PK, Strobel A, Schultheis M, Staubach P, Grabbe S, Hennig K, Matusiak L, von Stebut E, Garcovich S, Bayer H, Heise M, Kirschner U, Nikolakis G, Szepietowski JC. Krajewski PK, et al. Dermatology. 2024;240(2):205-215. doi: 10.1159/000536128. Epub 2024 Jan 8. Dermatology. 2024. PMID: 38190809
International Hidradenitis Suppurativa Severity Scoring System (IHS4) as a holistic measure of hidradenitis suppurativa disease severity compared with Hurley staging: A post hoc analysis of the SUNRISE and SUNSHINE phase 3 trials of secukinumab.
Zouboulis CC, Prens EP, Sayed CJ, Molina-Leyva A, Bettoli V, Romanelli M, Szepietowski JC, Martinez AL, Kasparek T, Lobach I, Wozniak MB, Ortmann CE, Thomas N, Bachhuber T, Ravichandran S, Tzellos T. Zouboulis CC, et al. Among authors: szepietowski jc. J Eur Acad Dermatol Venereol. 2024 Jun;38(6):e496-e499. doi: 10.1111/jdv.19681. Epub 2023 Dec 6. J Eur Acad Dermatol Venereol. 2024. PMID: 38058224 Clinical Trial. No abstract available.
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
Kimball AB, Jemec GBE, Sayed CJ, Kirby JS, Prens E, Ingram JR, Garg A, Gottlieb AB, Szepietowski JC, Bechara FG, Giamarellos-Bourboulis EJ, Fujita H, Rolleri R, Joshi P, Dokhe P, Muller E, Peterson L, Madden C, Bari M, Zouboulis CC. Kimball AB, et al. Among authors: szepietowski jc. Lancet. 2024 May 22:S0140-6736(24)00101-6. doi: 10.1016/S0140-6736(24)00101-6. Online ahead of print. Lancet. 2024. PMID: 38795716
Awareness of people using municipal swimming pools about the prevention, symptoms, and treatment of athlete's foot and onychomycosis before COVID-19.
Cisoń H, Kostrzewska P, Łątka N, Krajewski PK, Szepietowski J, Konsur-Jankowska A, Białynicki-Birula R, Reich A. Cisoń H, et al. Among authors: szepietowski j. Postepy Dermatol Alergol. 2024 Apr;41(2):226-231. doi: 10.5114/ada.2024.136083. Epub 2024 Mar 7. Postepy Dermatol Alergol. 2024. PMID: 38784926 Free PMC article.
643 results